Product Information
ACCRUFER 30 MG CAPSULE is a brand product labeled by Shield TX (UK) Ltd, priced at $10.0850 per EA under NDC 73059000160. Its NADAC has been published 207 times since Oct 19, 2022.
FDA first approved this application on Jul 25, 2019.
Strength
30 mg/1
Manufacturer
Shield TX (UK) LtdNDC
73059000160
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/1/2026
Active Ingredients
FERRIC MALTOLApproval Type
New Drug (NDA)
FDA Application
NDA212320FDA Approved
7/25/2019
On Market Since
7/1/2021
Pharmacological Classes
Price Statistics
The NADAC for ACCRUFER 30 MG CAPSULE has been published 207 times since Oct 19, 2022, and over the history we have for it it has risen 22.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0850 per EA |
|---|---|
| All-time high | $10.0850 (Sep 30, 2026) |
| All-time low | $8.2391 (Oct 19, 2022) |
| 52-week high | $10.0850 |
| 52-week low | $9.5336 |
| Median price | $9.0001 |
| Average price | $9.1372 |
| Largest weekly change | +6.0% (Jan 10, 2024) |
| Weeks tracked | 207 |
| Tracking since | Oct 19, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ferric Maltol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Shield TX (UK) Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ferric Maltol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Parenteral Iron Replacement class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACCRUFER 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ACCRUFER 30 MG CAPSULE, manufactured by Shield TX (UK) Ltd, is $10.0850 per EA (NDC 73059000160), effective Sep 30, 2026.
How has the price of ACCRUFER 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ACCRUFER 30 MG CAPSULE has risen 22.4%. It has been tracked across 207 weekly CMS publications since Oct 19, 2022.
What are the highest and lowest recorded NADAC prices for ACCRUFER 30 MG CAPSULE?
Since Oct 19, 2022, the NADAC for ACCRUFER 30 MG CAPSULE has ranged from a low of $8.2391 (Oct 19, 2022) to a high of $10.0850 (Sep 30, 2026), with a median of $9.0001 per EA.
Are there cheaper alternatives to ACCRUFER 30 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ACCRUFER 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ACCRUFER 30 MG CAPSULE?
ACCRUFER 30 MG CAPSULE (NDC 73059000160) is labeled by Shield TX (UK) Ltd, and CMS classifies it as a brand product.